Medindia

X

Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples

by Kathy Jones on  July 14, 2011 at 7:44 PM News on IT in Healthcare   - G J E 4
The number of cervical cancer screening samples needing human review could be cut down by as much as 25 percent after the United Kingdom National Health Service Cancer Screening Programmes (NHSCSP) approved the use of an automated technology to screen the samples.
 Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples
Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples
Advertisement

Developed by Source BioScience, the BD FocalPoint can automatically screen cervical cancer samples and provides a "no further review necessary" signal should it find no problems with the samples.

Advertisement
The automated service is expected to cut down the number of samples that require human review by nearly 900,000 with over 3.6 million samples being reviewed every year in England and Wales.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All